ATORX Stock Splits - Alligator Bioscience AB

Price: 4.683 SEK -5.96%

Market Cap: 80.6m SEK

The company executed a 1-for-1000 stock split, meaning that for every 1000 shares held, investors received 1 new share.

Before the split, ATORX traded at 0.0055 per share. Afterward, the share price was about 5.4.

The adjusted shares began trading on Apr 7, 2025. This was ATORX's 5th stock split, following the previous one in Jan 24, 2025.

Apr 7, 2025

1-for-1000

Jan 24, 2025

4861-for-411

Apr 25, 2023

33-for-20

Nov 9, 2021

155-for-142

Jan 4, 2021

318-for-305

Pre-Split Price

0.0055

Post-Split Price

5.4

Adjust Price

Apr 7, 2025

1-for-1000

Jan 24, 2025

4861-for-411

Apr 25, 2023

33-for-20

Nov 9, 2021

155-for-142

Jan 4, 2021

318-for-305

Alligator Bioscience AB
Stock Splits History

Logarithmic

Apr 7, 2025

Split 1-for-1000

/0.001

Pre-Split Price

5.5

Post-Split Price

5.4

Adjust Price

Jan 24, 2025

Split 4861-for-411

x11.827250608273

Pre-Split Price

14.1368

Post-Split Price

Adjust Price

Apr 25, 2023

Split 33-for-20

x1.65

Pre-Split Price

56.367

Post-Split Price

60.8764

Adjust Price

Nov 9, 2021

Split 155-for-142

x1.0915492957746

Pre-Split Price

109.147

Post-Split Price

112.4778

Adjust Price

Jan 4, 2021

Split 318-for-305

x1.0426229508197

Pre-Split Price

357.9553

Post-Split Price

364.2929

Adjust Price

Global
Stock Splits Monitor

Forward Splits

Reverse Splits

Adjust Price

Date	Company		Split	Pre-Split Price	Post-Split Price
Apr 22, 2025		Seres Therapeutics Inc SWB:1S9 1S9 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-20 /20	0.3216 6.432 EUR	6.432 6.432 EUR
Apr 22, 2025	G	Golden Shield Resources Inc F:4LE0 4LE0 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-10 /10	0.011 0.11 EUR	0.11 0.11 EUR
Apr 22, 2025	E	EV Advanced Material Co Ltd KOSDAQ:131400 131400 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	911-for-787 x1.1575603557814	1493 1493 KRW	1439 1439 KRW
Apr 22, 2025		Seres Therapeutics Inc F:1S9 1S9 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-20 /20	0.01 0.2 EUR	0.2 0.2 EUR
Apr 22, 2025	G	Golden Shield Resources Inc OTC:GSRFF GSRFF Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-10 /10	0.024 0.24 USD	0.24 0.24 USD

Alligator Bioscience AB
Glance View

Market Cap

80.6m SEK

Industry

Biotechnology

Alligator Bioscience AB is a biotech company, which engages in the development of innovative antibody-based medicines for immunotherapy of cancer. The company is headquartered in Lund, Skane and currently employs 46 full-time employees. The company went IPO on 2016-11-23. The firm specializes in the development of tumor-targeted immunotherapies, in particular agonist mono- and bispecific antibodies, and is active in the early stages of drug development, from concept to phase II clinical trials. Alligator’s pipeline includes the two key assets mitazalimab, a CD40 agonist, and ATOR-1017, a 4-1BB agonist. Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its technology platform, Neo-X-Prime, with MacroGenics Inc. and drug candidates based on the RUBY bispecific platform with Orion Corporation. Its licensed programs include AC101, in phase II development, by Shanghai Henlius Biotech Inc. and an undisclosed target to Biotheus Inc. The firm operates domestically.

View ATORX Analysis

ATORX Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

	Franklin Covey Co NYSE:FC	20.84 USD 0.29%
	Mohawk Industries Inc NYSE:MHK	107.16 USD 0.27%
	Ardmore Shipping Corp NYSE:ASC	9.59 USD 0.1%
	ASGN Inc NYSE:ASGN	51.21 USD -0.31%
	Skyworks Solutions Inc NASDAQ:SWKS	61.51 USD -0.02%
	Weatherford International PLC NASDAQ:WFRD	42.525 USD -0.5%

	Johnson & Johnson NYSE:JNJ	155.205 USD 0.4%
	Bank of America Corp NYSE:BAC	39.805 USD 0.29%
	Mastercard Inc NYSE:MA	536.25 USD 0.52%
	Salesforce Inc NYSE:CRM	266.14 USD -0.64%
	Abbvie Inc NYSE:ABBV	189.385 USD 1.79%
	Home Depot Inc NYSE:HD	358.23 USD 0.18%

	Arista Networks Inc NYSE:ANET	77.99 USD 0.1%
	Visa Inc NYSE:V	337.32 USD 0.64%
	Texas Pacific Land Corp NYSE:TPL	1 330.97 USD -0.27%
	KLA Corp NASDAQ:KLAC	686.44 USD -1.18%
	Manhattan Associates Inc NASDAQ:MANH	174.06 USD -0.3%
	Monolithic Power Systems Inc NASDAQ:MPWR	575.435 USD -1.42%

Alligator Bioscience AB
STO:ATORX

ATORX's latest stock split occurred on Apr 7, 2025

Alligator Bioscience AB
Stock Splits History

Global
Stock Splits Monitor

Alligator Bioscience AB
Glance View

Company

Help

Tools

Stocks

	ServiceNow Inc NYSE:NOW	938.455 USD -0.72%
	EOG Resources Inc NYSE:EOG	113.24 USD 0.15%
	Monster Beverage Corp NASDAQ:MNST	58.655 USD -0.03%
	Copart Inc NASDAQ:CPRT	60.35 USD -0.9%
	Applied Materials Inc NASDAQ:AMAT	149.05 USD -1.65%
	Airbnb Inc NASDAQ:ABNB	124.205 USD 1.38%

52 Week Range	4.683 124.1201
Price Target

Alligator Bioscience AB STO:ATORX

ATORX's latest stock split occurred on Apr 7, 2025

Alligator Bioscience AB Stock Splits History

Global Stock Splits Monitor

Alligator Bioscience AB Glance View

Company

Help

Tools

Stocks

Alligator Bioscience AB
STO:ATORX

Alligator Bioscience AB
Stock Splits History

Global
Stock Splits Monitor

Alligator Bioscience AB
Glance View